erlotinib has been researched along with n-(4(n-((2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino)benzoyl)-l-glutamic acid in 1 studies
Studies (erlotinib) | Trials (erlotinib) | Recent Studies (post-2010) (erlotinib) | Studies (n-(4(n-((2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino)benzoyl)-l-glutamic acid) | Trials (n-(4(n-((2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino)benzoyl)-l-glutamic acid) | Recent Studies (post-2010) (n-(4(n-((2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino)benzoyl)-l-glutamic acid) |
---|---|---|---|---|---|
221 | 0 | 180 | 25 | 0 | 1 |
Protein | Taxonomy | erlotinib (IC50) | n-(4(n-((2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino)benzoyl)-l-glutamic acid (IC50) |
---|---|---|---|
Thymidylate synthase | Escherichia coli | 0.0552 | |
Dihydrofolate reductase | Homo sapiens (human) | 2.1867 | |
Dihydrofolate reductase | Mus musculus (house mouse) | 6.8 | |
Dihydrofolate reductase | Lacticaseibacillus casei | 3.274 | |
Thymidylate synthase | Lacticaseibacillus casei | 0.0277 | |
Thymidylate synthase | Homo sapiens (human) | 0.068 | |
Thymidylate synthase | Mus musculus (house mouse) | 2.3752 | |
Thymidylate synthase | Rattus norvegicus (Norway rat) | 0.36 | |
Bifunctional dihydrofolate reductase-thymidylate synthase | Toxoplasma gondii | 0.2636 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bailey-Downs, LC; Gangjee, A; Ihnat, MA; Kisliuk, RL; Thorpe, JE; Zhao, Y | 1 |
1 other study(ies) available for erlotinib and n-(4(n-((2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino)benzoyl)-l-glutamic acid
Article | Year |
---|---|
Novel tricyclic indeno[2,1-d]pyrimidines with dual antiangiogenic and cytotoxic activities as potent antitumor agents.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chick Embryo; Drug Screening Assays, Antitumor; Humans; Indenes; Melanoma, Experimental; Mice; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta | 2012 |